Side Effects and Memory Loss Associated with Electroconvulsive Therapy (ECT)

Electroconvulsive therapy (ECT) is a medical treatment that involves passing electrical currents through the brain to induce a seizure. While side effects of ECT are rare, some patients may experience memory loss. During the course of ECT, patients may have difficulty remembering newly learned information, but this typically improves in the days and weeks following treatment. However, some patients may experience partial loss of memory for events that occurred before ECT, which may take longer to recover.

Despite these potential memory issues, some patients report improved memory ability following ECT, as it can remove the amnesia associated with severe depression. It is important to note that cardiac arrhythmia may be stimulated by the electrical shock of ECT, but musculoskeletal injury is rare with adequate anesthesia.

It is also important to dispel the myth that ECT can cause dementia. Dementia is an organic illness that is not induced by ECT. Research has not found a link between ECT and dementia, but this remains an area of focus for further study. Overall, while ECT may have some potential side effects, it can be a highly effective treatment for severe depression and other mental health conditions.

Brachial Artery Trauma in Humeral Shaft Fractures

The brachial artery, which runs around the midshaft of the humerus, can be affected by trauma when the humeral shaft is fractured. The extent of the damage can vary, from pressure occlusion to partial or complete transection, and may also involve mural contusion with secondary thrombosis. To determine the nature of the damage, an arteriogram should be performed. Appropriate surgery, in combination with fracture fixation, should then be undertaken to address the injury. It is important to promptly assess and treat brachial artery trauma in humeral shaft fractures to prevent further complications and ensure proper healing.

Cauda equina syndrome typically manifests as lower back pain, sciatica, and decreased sensation in the perianal area. As the condition progresses, urinary incontinence may develop, which is a concerning late sign associated with irreversible damage. While a positive sciatic stretch test indicates nerve irritation or compression, it does not necessarily indicate spinal cord compression. Reduced perianal sensation is also a red flag, but it typically appears earlier than urinary incontinence. Although tingling in one leg may be caused by sciatic nerve irritation, it is not a specific sign of cauda equina syndrome, particularly if it is unilateral. While assessing anal tone is important, studies have shown that it has low sensitivity and specificity for detecting cauda equina syndrome.

Cauda equina syndrome (CES) is a rare but serious condition that occurs when the nerve roots in the lower back are compressed. It is crucial to consider CES in patients who present with new or worsening lower back pain, as a late diagnosis can result in permanent nerve damage and long-term leg weakness and urinary/bowel incontinence. The most common cause of CES is a central disc prolapse, typically at L4/5 or L5/S1, but it can also be caused by tumors, infections, trauma, or hematomas. CES can present in various ways, and there is no single symptom or sign that can diagnose or exclude it. Possible features include low back pain, bilateral sciatica, reduced sensation in the perianal area, decreased anal tone, and urinary dysfunction. Urgent MRI is necessary for diagnosis, and surgical decompression is the recommended management.

Investigations for a Patient with Stroke and Suspected Multiple Myeloma

When a patient presents with symptoms of stroke and possible multiple myeloma, several investigations may be necessary to confirm the diagnosis and determine the cause of the stroke. The mnemonic CRAB (high Calcium, Renal insufficiency, Anaemia and Bone lesions) can help identify the key symptoms of multiple myeloma.

One potential test is a urinary Bence Jones protein test, which can confirm the presence of multiple myeloma. However, this test alone cannot determine the cause of the stroke.

An MRI of the head may show areas of damage, but it will not reveal the cause of the stroke. A CT scan of the head, on the other hand, can identify changes caused by an ischaemic stroke, but it cannot differentiate the cause of the clot.

Liver function tests and X-rays of the spine are not first-line investigations for this condition, but they may be useful in identifying bone lesions associated with multiple myeloma.

Overall, a combination of tests and imaging may be necessary to diagnose and treat a patient with stroke and suspected multiple myeloma.

Regular monitoring of weight and height is recommended every 6 months for patients taking methylphenidate, a stimulant medication. This is important as the drug may cause appetite suppression and growth impairment in children. Additionally, blood pressure and pulse should also be monitored regularly.

In March 2018, NICE released new guidelines for identifying and managing Attention Deficit Hyperactivity Disorder (ADHD). This condition can have a significant impact on a child’s life and can continue into adulthood, making accurate diagnosis and treatment crucial. According to DSM-V, ADHD is characterized by persistent features of inattention and/or hyperactivity/impulsivity, with an element of developmental delay. Children up to the age of 16 must exhibit six of these features, while those aged 17 or over must exhibit five. ADHD has a UK prevalence of 2.4%, with a higher incidence in boys than girls, and there may be a genetic component.

NICE recommends a holistic approach to treating ADHD that is not solely reliant on medication. After presentation, a ten-week observation period should be implemented to determine if symptoms change or resolve. If symptoms persist, referral to secondary care is necessary, typically to a paediatrician with a special interest in behavioural disorders or to the local Child and Adolescent Mental Health Service (CAMHS). A tailored plan of action should be developed, taking into account the patient’s needs and wants, as well as how their condition affects their lives.

Drug therapy should be considered a last resort and is only available to those aged 5 years or older. Parents of children with mild/moderate symptoms can benefit from attending education and training programmes. For those who do not respond or have severe symptoms, pharmacotherapy may be considered. Methylphenidate is the first-line treatment for children and should be given on a six-week trial basis. It is a CNS stimulant that primarily acts as a dopamine/norepinephrine reuptake inhibitor. Side effects include abdominal pain, nausea, and dyspepsia. Weight and height should be monitored every six months in children. If there is an inadequate response, lisdexamfetamine should be considered, followed by dexamfetamine if necessary. In adults, methylphenidate or lisdexamfetamine are the first-line options, with switching between drugs if no benefit is seen after a trial of the other. All of these drugs are potentially cardiotoxic, so a baseline ECG should be performed before starting treatment, and referral to a cardiologist should be made if there is any significant past medical history or family history, or any doubt or ambiguity.

As with most psychiatric conditions, a thorough history and clinical examination are essential, particularly given the overlap of ADHD with many other psychiatric and

Topical Treatments for Chronic Plaque Psoriasis: NICE Recommendations

Chronic plaque psoriasis is a common skin condition that can be managed with topical treatments. The National Institute for Health and Care Excellence (NICE) recommends a stepwise approach to treatment, with different options depending on the severity of the condition and the response to previous therapies.

First-line treatment for chronic plaque psoriasis is a potent corticosteroid applied once daily, combined with a vitamin D analogue, for up to 4 weeks. This combination therapy has been shown to be effective in reducing inflammation and improving symptoms.

If there is no improvement with both steroid and calcipotriol after 8 weeks, topical calcipotriol alone can be used as a second-line management option. However, it is insufficient to prescribe alone as a first-line treatment.

Topical steroid alone is a third-line management option for psoriasis if there is no improvement after 8-12 weeks. This is because long-term use of topical steroids can have side effects such as skin thinning and increased risk of infection.

Short-acting dithranol could be used as a fourth-line option, but not as initial management. Topical coal tar is also part of third-line management for psoriasis.

In summary, the NICE recommendations for topical treatments for chronic plaque psoriasis involve a stepwise approach, with combination therapy as the first-line option and other treatments used if there is no improvement or if side effects occur. It is important to work with a healthcare provider to find the most effective and safe treatment plan for each individual.

NICE Recommendations for Topical Treatments for Chronic Plaque Psoriasis

Diagnostic Tests for Benign Prostatic Hyperplasia

Benign prostatic hyperplasia is a common condition in older men that can cause urinary symptoms. To diagnose this condition, several diagnostic tests can be used. One of the most common tests is an ultrasound pelvis with post-void bladder volume, which can estimate the degree of bladder obstruction.

However, other tests such as CT abdomen and MRI abdomen are not useful for diagnosing benign prostatic hyperplasia. CT abdomen is more useful for diagnosing malignancies of the pelvic-ureteric system, while MRI abdomen is more sensitive for diagnosing lymph-node metastasis in prostate cancer.

Micturating cystourethrogram is also not useful for diagnosing prostatic hypertrophy, as it is used to diagnose fistula, vesicoureteric reflux, and urethral stricture. Similarly, serum alpha-fetoprotein has no role in cancer of the prostate, as it is a tumour marker in hepatocellular carcinoma, non-seminomatous germ-cell tumours, and yolk-sac tumours.

In conclusion, an ultrasound pelvis with post-void bladder volume is the most useful diagnostic test for benign prostatic hyperplasia.

Cervical Screening and Referral Guidelines

Routine Screening and Recall

Women between the ages of 25 and 49 are screened for cervical cancer every three years. If a smear sample is negative for high-risk (HR) human papillomavirus (HPV), the patient is referred back to routine recall according to her age group.

Referral to Colposcopy

If reflex HR HPV testing is positive, the patient is referred to colposcopy for further assessment within six weeks. Women with high-grade dyskaryosis or abnormalities in glandular cells are referred to colposcopy as urgent appointments to be seen within two weeks. Women with borderline or mild dyskaryosis and who are HR HPV positive are referred to colposcopy as routine appointments to be seen within six weeks.

HPV Test of Cure

Women who have undergone treatment for cervical disease are offered an HPV test of cure six months after treatment. If the test is negative for dyskaryosis and HR HPV, the woman is recalled in three years. If the 6-month post-treatment test is negative for dyskaryosis but positive for HR HPV, the woman is re-referred to colposcopy. If there is evidence of high-grade dyskaryosis, the woman is referred back to colposcopy for reassessment.

Recall Frequency

Women aged 25-49 are recalled for routine screening every three years. Women aged 50-64 are recalled every five years.

Management of Suspected Meningococcal Meningitis: Importance of Early Diagnosis and Treatment

This article discusses the management of suspected meningococcal meningitis, a serious and potentially life-threatening condition caused by Neisseria meningitidis. Early diagnosis and treatment are crucial to prevent complications and contain the spread of the disease.

Clinical Diagnosis
The classic triad of symptoms associated with meningococcal meningitis includes fever, headache, and meningeal signs, usually in the form of neck stiffness. A non-blanching rash is also a common feature. Medical practitioners have a statutory obligation to notify Public Health England on clinical suspicion of meningococcal meningitis and septicaemia, without waiting for microbiological confirmation.

Upon Microbiological Diagnosis
Delay in notifying the communicable disease consultant of a suspected case of meningococcal meningitis can lead to a delay in contact tracing and outbreak management. Upon culture and isolation, the patient should be administered a stat dose of intramuscular or intravenous benzylpenicillin. Samples should be obtained before administration of antibiotics, including blood for cultures and PCR, CSF for microscopy, culture, and PCR, and nasopharyngeal swab for culture. The patient should be kept in isolation, Public Health England notified, and contacts traced.

Upon Treatment
Early treatment with intramuscular or intravenous benzylpenicillin is essential to prevent complications and reduce mortality. Treatment should be administered at the earliest opportunity, either in primary or secondary care.

After Discharge
Alerting the communicable disease consultant after discharge is too late to track and treat other individuals at risk. Therefore, it is crucial to notify Public Health England and trace contacts as soon as a suspected case of meningococcal meningitis is identified.

Management of Acute Exacerbation of COPD: Considerations and Interventions

When managing a patient with acute exacerbation of chronic obstructive pulmonary disease (COPD), it is important to consider various interventions based on the patient’s clinical presentation. In this case, the patient has increased oxygen saturations, which may be contributing to confusion. It is crucial to avoid over-administration of oxygen, as it may worsen breathing function. An arterial blood gas can guide oxygen therapy and help determine the appropriate treatment, such as reducing oxygen concentration or initiating steroid therapy.

IV aminophylline may be considered if nebulisers and steroids have not been effective, but it is not necessary in this case. Pulmonary function testing is not beneficial in immediate management. Intubation is not currently indicated, as the patient’s confusion is likely due to excessive oxygen administration.

Antibiotics may be necessary if there is evidence of infection, but in this case, an arterial blood gas is the most important step. Overall, management of acute exacerbation of COPD requires careful consideration of the patient’s clinical presentation and appropriate interventions based on their individual needs.